<Record>
<Term>SDZ 280-446</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Multidrug Resistance Modulator</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Multidrug Resistance Modulator/SDZ 280-446</ClassificationPath>
<BroaderTerm>SDZ 280-446</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Multidrug Resistance Modulator</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>SDZ 280-446</Synonym>
<Description>A novel semi-synthetic derivative of cyclosporin and a cyclodepsipeptide with chemo-sensitizing activity. SDZ 280-446 is one of the drug resistance-modifying agents that inhibit P-glycoprotein, the multidrug resistance efflux pump, thereby restoring the retention and activities of some drugs in drug-resistant tumor cells.</Description>
<Source>NCI Thesaurus</Source>
</Record>
